Prime Therapeutics (Prime) once again has a robust presence at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting in Houston from March 31–April 3. AMCP is the nation’s leading professional association that aims to help patients get the medications they need at a cost they can afford. This event annually attracts more than 4,000 industry leaders, health care professionals and stakeholders committed to advancing the field. Prime’s teams will present research posters and educational sessions on health outcomes research. 

Press release 

Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025
Prime to present seven studies and receive the 2024 JMCP Award for Excellence
Read more »

Stories

Look for Prime Therapeutics at AMCP 2025
From research posters and education sessions to the Pharmacy Friends podcast, Prime has you covered on the latest managed care pharmacy insights
Read more »

Prime Therapeutics presents seven research posters at AMCP Annual Meeting 2025
Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model
Read more »

Prime Therapeutics GLP-1 research at AMCP offers additional perspectives to obesity treatment
Leading GLP-1 persistence, adherence and clinical outcomes research helps inform health plans and members
Read more »

Podcast

LISTEN NOW: A behind-the-scenes look at the research — Decoding health outcomes at AMCP 2025
Hear the first part of a two-part preview of the research the Prime Therapeutics health outcomes team will present at the annual managed care pharmacy event
Read more »
 

In the news

Managed Healthcare Executive: 
Prime Therapeutics Finds No Medical Cost Offsets for GLP-1 Obesity Drugs | AMCP Annual 2025
A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control group
Read more »